Whitener Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Whitener Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $18,601 - $24,263	-378 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $5,517 - $6,541	129 Added 51.81%	378 $19,000
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $44 - $49	1 Added 0.4%	249 $11,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $27,929 - $33,302	-619 Reduced 71.4%	248 $11,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $48 - $63	1 Added 0.12%	867 $45,000
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $47,794 - $53,908	866 New	866 $53,000
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $53,763 - $67,010	-1,064 Closed	0 $0
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $30,738 - $35,386	-513 Reduced 32.53%	1,064 $67,000
Q4 2017 Apr 23, 2018	BUY	$59.94 - $65.35 $94,525 - $103,056	1,577	1,577 $96,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.